Belzutifan
About
Therapy type: Targeted therapy
Therapy strategy: HIF-2a inhibition
Mappings
NCI Thesaurus: Belzutifan (ncit:C135627)
RxNorm: belzutifan (rxcui:2567226, omop:701696)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| EMA (1) FDA (1) | VHL pathogenic variants | Renal Cell Carcinoma | Belzutifan | |
| EMA (1) FDA (1) | VHL pathogenic variants | Central Nervous System Hemangioblastoma | Belzutifan | |
| EMA (1) FDA (1) | VHL pathogenic variants | Pancreatic Neuroendocrine Tumor | Belzutifan |